Author

M. Guitian

Observed names: M. D. Guitian, Maria Guitian

Institution: Universidad de Navarra

Observed institutions: Hospital Clínico San Carlos, Centro Oncológico de Galicia, Fundación Instituto Valenciano de Oncología, Centro de Investigación del Cáncer, Universidad Panamericana, campus Ciudad de México, Universidad Panamericana, Universidad de Navarra

OpenAlex ID: A5082014328

Randomized Phase 3 Trial of Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer

2008 · M. Martin, A. Rodriguez-Lescure, et al. · JNCI Journal of the National Cancer Institute · 240

Subgroup analysis of GEICAM 9906 trial comparing six cycles of FE90C (FEC) to four cycles of FE90C followed by 8 weekly paclitaxel administrations (FECP): Relevance of HER2 and hormonal status (HR)

2007 · Á. Rodríguez-Lescure, M. Martín, et al. · Journal of Clinical Oncology · 10

The Role of Nutrition in HPV Infection and Cervical Cancer Development: A Review of Protective Dietary Factors

2025 · Maria Guitian, Gabriel Reina, et al. · Cancers · 2

Sun-207 Longitudinal Follow-up of Incident Chronic Kidney Disease (ckd) in the Keep Mexico Ckd Screening Program

2019 · G. Obrador Vera, A. Villa, et al. · Kidney International Reports · 1

Works count: 4

Citation count: 253

H-index: 2

I10-index: 2